These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 14578850)
1. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. Ito H; Ando K; Nakayama T; Taniguchi M; Ezaki T; Saito K; Takemura M; Sekikawa K; Imawari M; Seishima M; Moriwaki H Hepatology; 2003 Nov; 38(5):1116-24. PubMed ID: 14578850 [TBL] [Abstract][Full Text] [Related]
2. Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction. Habu Y; Shinomiya N; Kinoshita M; Matsumoto A; Kawabata T; Seki S Clin Exp Med; 2007 Mar; 7(1):30-8. PubMed ID: 17380303 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment. Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134 [TBL] [Abstract][Full Text] [Related]
4. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Nakashima H; Inui T; Habu Y; Kinoshita M; Nagao S; Kawaguchi A; Miura S; Shinomiya N; Yagita H; Seki S Gastroenterology; 2006 Nov; 131(5):1573-83. PubMed ID: 17064698 [TBL] [Abstract][Full Text] [Related]
5. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033 [TBL] [Abstract][Full Text] [Related]
6. A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide. Cao Z; Dhupar R; Cai C; Li P; Billiar TR; Geller DA J Immunol; 2010 Aug; 185(4):2536-43. PubMed ID: 20624945 [TBL] [Abstract][Full Text] [Related]
7. Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice. Inui T; Nakashima H; Habu Y; Nakagawa R; Fukasawa M; Kinoshita M; Shinomiya N; Seki S J Hepatol; 2005 Oct; 43(4):670-8. PubMed ID: 15922476 [TBL] [Abstract][Full Text] [Related]
8. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide. Tulley JM; Palmer JL; Gamelli RL; Faunce DE Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934 [TBL] [Abstract][Full Text] [Related]
9. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616 [TBL] [Abstract][Full Text] [Related]
10. Normal liver regeneration and liver cell apoptosis after partial hepatectomy in tumor necrosis factor-alpha-deficient mice. Hayashi H; Nagaki M; Imose M; Osawa Y; Kimura K; Takai S; Imao M; Naiki T; Kato T; Moriwaki H Liver Int; 2005 Feb; 25(1):162-70. PubMed ID: 15698414 [TBL] [Abstract][Full Text] [Related]
11. Innate immune responses involving natural killer and natural killer T cells promote liver regeneration after partial hepatectomy in mice. Hosoya S; Ikejima K; Takeda K; Arai K; Ishikawa S; Yamagata H; Aoyama T; Kon K; Yamashina S; Watanabe S Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G293-9. PubMed ID: 23086918 [TBL] [Abstract][Full Text] [Related]
12. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2. Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231 [TBL] [Abstract][Full Text] [Related]
13. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo. Chamoto K; Takeshima T; Kosaka A; Tsuji T; Matsuzaki J; Togashi Y; Ikeda H; Nishimura T Immunol Lett; 2004 Aug; 95(1):5-11. PubMed ID: 15325792 [TBL] [Abstract][Full Text] [Related]
14. Selective elimination of hepatic natural killer T cells with concanavalin A improves liver regeneration in mice. Huang W; Dong Z; Wei H; Ding C; Sun R; Tian Z Liver Int; 2006 Apr; 26(3):339-45. PubMed ID: 16584397 [TBL] [Abstract][Full Text] [Related]
15. Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation. Oshima T; Sonoda KH; Nakao S; Hijioka K; Taniguchi M; Ishibashi T Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):105-12. PubMed ID: 18172081 [TBL] [Abstract][Full Text] [Related]
16. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors. Biburger M; Tiegs G J Leukoc Biol; 2008 Jul; 84(1):264-79. PubMed ID: 18407967 [TBL] [Abstract][Full Text] [Related]
17. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Minagawa M; Oya H; Yamamoto S; Shimizu T; Bannai M; Kawamura H; Hatakeyama K; Abo T Hepatology; 2000 Apr; 31(4):907-15. PubMed ID: 10733547 [TBL] [Abstract][Full Text] [Related]